| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Jean Jacques Bienaime is Director at BMRN and has filed Form 4s across 6 companies. From September 2015 to August 2026, the filings on record show 21 open-market purchases and 123 sales. Jean Jacques Bienaime's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $31.2M at current prices.
Historically, Jean Jacques Bienaime's trades have earned a middling insider score of 68/100 across 67 rated trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +8.5%.
The biggest single holding is BMRN (~$26.4M) as Director. The BMRN filings lean toward selling, a net 2,115,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2018 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $84.63 | $846,285.00 | -4.2% | |
| Jan 5, 2018 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $90.32 | $903,203.00 | -4.2% | |
| Dec 29, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 20,000 | $89.75 | $1,795,037.00 | -8.1% | |
| Sep 13, 2017 | IMUX Immunic, Inc. | Director | Buy | 10,000 | $4.00 | $39,969.00 | +18.1% | |
| Jun 13, 2017 | IMUX Immunic, Inc. | Director | Buy | 16,000 | $3.00 | $48,068.80 | +40.9% | |
| Jun 5, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $90.13 | $901,300.00 | -4.2% | |
| Jun 1, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 5,000 | $87.53 | $437,650.00 | -2.1% | |
| May 31, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 7,423 | $88.29 | $655,376.67 | -3.1% | |
| May 24, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 5,000 | $88.38 | $441,900.00 | -2.1% | |
| May 17, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 5,000 | $91.73 | $458,650.00 | -2.1% |